Atlas Trials

Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy

Clinical trial NCT04418648 · TERMINATED

Trial details

NCT number
NCT04418648
Sponsor
Sun Yat-sen University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Cancer Limited Stage
Start date
2020-06-01
Primary completion
2024-05-31
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.